Physiology AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


News Physiol Sci 15: 107-113, 2000;
1548-9213/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walzog, B.
Right arrow Articles by Gaehtgens, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walzog, B.
Right arrow Articles by Gaehtgens, P.
News in Physiological Sciences, Vol. 15, No. 3, 107-113, June 2000
© 2000 Int. Union Physiol. Sci./Am. Physiol. Soc.

Adhesion Molecules: The Path to a New Understanding of Acute Inflammation

Barbara Walzog and Peter Gaehtgens

B. Walzog and P. Gaehtgens are in the Department of Physiology, Freie Universität Berlin, Arnimallee 22, D-14195 Berlin, Germany.

    Abstract
 
About 100 years after the definition of the basic principles of inflammation, the identification of the underlying molecular mechanisms provides a new understanding of the inflammatory response. The specificity and diversity of the adhesion molecules involved in leukocyte extravasation account for the ordered leukocyte recruitment and activation in inflammation.


    Introduction
 Top
 Introduction
 How are leukocytes made...
 How do leukocytes penetrate...
 How is the inflammatory...
 References
 
At the end of the last century, Elie Metchnikoff laid the foundation for the biological theory of inflammation by realizing that the acute inflammatory response "consists in a reaction of phagocytes against a harmful agent" (8). In the following 100 years, this theory was consolidated and extended by recognizing the molecular mechanisms that underlie the activation and recruitment of the leukocytes from the circulation and their trafficking through the body. The identification of the nature of adhesion molecules and inflammatory mediators involved not only expanded our knowledge of the molecular mechanisms but also provided the basis for a new understanding of the inflammatory response and its role in tissue homeostasis. This review focuses on the importance of adhesion molecules in the control of acute inflammation, which is characterized by immediate infiltration of polymorphonuclear neutrophils (PMN) at sites of lesion, followed by monocytes and eventually lymphocytes.

Human host defense includes physical and chemical barriers, e.g., skin and mucous membranes as well as gastric acidity or secretory and excretory flow, and so forth. Agents that overcome these barriers are faced with the innate and/or acquired defense mechanisms designed to recognize and eliminate foreign materials. These mechanisms, which are based on the sophisticated functions of the leukocytes, are also responsible for the elimination of old, damaged, or "unwanted" cells and thereby contribute to the maintenance of tissue homeostasis. Thus host defense mechanisms not only protect the organism from infection but also allow the removal of cell debris and destroyed tissue components that may result, for example, from ischemia or trauma. As a part of the innate defense, the acute inflammatory response that is elicited on these biological, chemical, or physical noxae allows leukocyte recruitment, i.e., the rapid and site-directed traveling of leukocytes to their target regions within the body, the first of four prerequisites for an effective host defense at sites of lesion. In a second step, leukocytes develop specific instruments that are responsible for the elimination of foreign materials or damaged tissue cells. This destructive potential of the leukocytes is prevented from causing uncontrolled tissue damage by containment mechanisms allowing graduation and finally resolution of the acute inflammatory response. Finally, inflammation gives rise to the process of repair and wound healing, which permits restitutio ad integrum.


    How are leukocytes made to leave the circulation? The multistep paradigm of leukocyte recruitment
 Top
 Introduction
 How are leukocytes made...
 How do leukocytes penetrate...
 How is the inflammatory...
 References
 
Metchnikoff (8) was convinced that leukocyte recruitment represents an active process that is managed by the leukocytes alone, whereas Cohnheim (4) and other investigators had the idea that leukocyte emigration depends on the properties of the vessel wall. The identification of the molecules involved in this recruitment process showed that emigration depends on sophisticated interaction between leukocytes and endothelial cells, to which both cell types actively contribute by expressing adhesion molecules on their surfaces and secreting soluble mediators. The sequence of events that allows the traveling of leukocytes to sites of host defense is designated the multistep paradigm of leukocyte recruitment (10). It involves margination and capturing of free-flowing leukocytes, leukocyte rolling, activation, firm adhesion, and spreading, transendothelial diapedesis, and chemotactic migration of the leukocytes (Fig. 1Go). The prerequisite for all of these steps is the activation of the endothelial cell monolayer by tissue-derived signals that induce the expression of endothelial adhesion molecules and trigger the secretion of inflammatory mediators by endothelial cells.



View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 1. The multistep paradigm of leukocyte recruitment. PMN, polymorphonuclear neutrophils; EC, endothelial cells.

 
Since leukocytes represent the largest particles in the circulating blood, they normally tend to travel in the axial blood stream of the microvessels. Hydrodynamic margination, i.e., radial displacement and retardation, is therefore required to bring the white blood cells into a critical proximity to the endothelial cell monolayer lining the blood vessels. This allows the initial cell-to-cell contact between leukocytes and endothelial cells mediated by adhesion molecules: the capturing of free-flowing leukocytes. The subsequent leukocyte rolling along the vessel wall is supported by transient contacts between adhesion molecules of activated endothelial cells and leukocytes. Due to their reduced speed, leukocytes are now sufficiently exposed to inflammatory mediators secreted by the endothelial cells, and, if activated, firmly adhere via their adhesion molecules and spread on the endothelial surface. This is the prerequisite for transendothelial migration, which is in general thought to occur through the intercellular junctions of neighboring endothelial cells. This process is not only due to locomotion of the leukocytes but also requires an active contribution of the transmigrated endothelial cells. Thereby, the cells exhibit adhesion molecule-mediated cell-to-cell contacts that guide the leukocytes in a way that is not yet entirely understood. After passing the basement membrane, leukocytes migrate chemotactically toward their final destination—a process that was originally recognized by Rudolf Virchow (11)—and are again directed by adhesion molecule interaction with the elements of the tissue fiber matrix.

Although leukocyte recruitment generally follows these basic principles, the underlying molecular mechanisms show great versatility in detail. Depending on the inflammatory stimulus, the leukocyte population recruited, the tissue, and the context of activation, different adhesion molecules and inflammatory mediators are involved. This allows the temporal and spatial regulation of targeting distinct leukocyte populations to distinct destinations within the body. During acute inflammation, PMN are mobilized within minutes to hours upon stimulation, whereas monocytes accumulate at sites of lesion with a time lag of approximately one day. PMN (and monocytes) emigrate from postcapillary venules, and naive lymphocytes emigrate preferentially from venules in secondary lymphoid organs, which, due to their characteristic endothelial lining, are called high-endothelial venules (HEV). Lymphocytes reenter the blood stream and recirculate with preference for a specific tissue (homing). Memory lymphocytes are known to emigrate primarily from post-capillary venules and enter "their" secondary lymphoid organ via the afferent lymph.


    How do leukocytes penetrate tissue in a targeted fashion? A pivotal role for adhesion molecules
 Top
 Introduction
 How are leukocytes made...
 How do leukocytes penetrate...
 How is the inflammatory...
 References
 
In inflammation, soluble mediators initiate cellular activation of leukocytes and endothelial cells, whereas adhesion molecules allow the interaction of free-flowing leukocytes with the vessel wall and all subsequent adhesive interactions that are required for emigration into the tissue. The diversity and specificity of the engaged adhesion molecules account for the ordered leukocyte recruitment, which allows that leukocytes meet and finally eliminate foreign particles with great efficiency within a reasonable time.

Various families of adhesion molecules are involved in leukocyte-endothelial cell interactions. These include selectins, integrins, immunoglobulins, and other molecules as listed in Table 1Go. Expressed on the cell surface, adhesion molecules recognize and bind specific ligands, e.g., other adhesion molecules or extracellular matrix proteins, and thereby mediate cell-cell and cell-substrate interactions. All adhesion molecules show a characteristic cellular distribution. Variations are due, for example, to the level of expression, posttranslational modification of the molecules, differential splicing, constitutive and/or inducible expression following cellular activation, and so forth.


View this table:
[in this window]
[in a new window]
 
Table 1. Adhesion molecules involved in leukocyte trafficking
 
Selectins.
The selectin family consists of three different molecules: L-selectin, P-selectin, and E-selectin, which play an important role in leukocyte capturing and rolling on endothelial cells (7). L-selectin is constitutively expressed on almost all leukocytes (L) and only virtually absent on a subset of memory lymphocytes. Whereas L-selectin expression is restricted to leukocytes, P-selectin is constitutively expressed on platelets (P) and induced, for example, on thrombin- or histamine-activated endothelial cells. E-selectin is expressed on activated endothelial (E) cells on stimulation by, for example, tumor necrosis factor-{alpha} (TNF-{alpha}) or interleukin 1. All selectins are monomeric molecules that span the plasma membrane once and contain a short epidermal growth factor-like repeat and two (L), six (E), or nine (P) complement control protein-like repeats (Fig. 2Go). The characteristic Ca2+-dependent lektin domain at the NH2 terminus defines their affinity to specific carbohydrate ligands.



View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 2. Structure of adhesion molecules involved in leukocyte recruitment. ICAM, intercellular adhesion molecule; VCAM, vascular adhesion molecule; PECAM, platelet endothelial cell adhesion molecule.

 
L-selectin binds several ligands, including glycam-1, CD34, and MAdCAM-1 on high endothelial venules, a yet-unidentified inducible ligand on activated microvascular endothelium in postcapillary venules, and an unidentified constitutive ligand on PMN, which is probably different from the P-selectin ligand PSGL-1, on leukocytes. All L-selectin ligands identified so far share common features: they are sialylated, fucosylated, sulfated, and show similarity to sialyl Lewis x and Lewis x. An important function of selectins is defined by their ability to bind carbohydrate ligands within milliseconds, thereby capturing free-flowing leukocytes from the bloodstream. This allows subsequent leukocyte rolling, which markedly decreases the traveling speed of the leukocytes from >2000 µm/s to <50 µm/s. This specialized function, which represents a hallmark of leukocyte recruitment, requires rapid association and dissociation of the selectin-ligand interaction and is well defined, especially for L-selectin. Contact initiation of free-flowing leukocytes is further supported by the exposed localization of L-selectin at the tips of microvilli (13). On PMN activation by, for example, soluble mediators, L-selectin is proteolytically cleaved from the cell surface by the action of a specific enzyme and the shed extracellular portion of the molecule, soluble or sL-selectin, is present in the plasma. There is broad conformity in the literature that sL-selectin levels in the plasma are elevated in infectious diseases and inflammation, which can be regarded as a rather nonspecific phenomenon reflecting elevated leukocyte counts in the circulation and/or enhanced leukocyte turnover. Although sL-selectin has been proposed to act as a putative competitive inhibitor of membrane-bound L-selectin, its functional relevance remains to be proven. Other data support the concept that shedding of L-selectin from the leukocyte surface controls the rolling velocity, which in turn has an impact on the transit time of the leukocytes. Thus L-selectin shedding may reduce the exposure of the leukocytes to endothelial-derived inflammatory mediators and thereby may restrict extravasation.

P-selectin and E-selectin also contribute to leukocyte rolling on the activated endothelial surface. P-selectin is stored in the Weibel-Palade bodies of endothelial cells and in the {alpha}-granules of platelets. On activation of endothelial cells, P-selectin is rapidly recruited to the cell surface, whereas E-selectin expression requires de novo synthesis induced by several inflammatory mediators. Both P- and E-selectin bind carbohydrate ligands on leukocytes and thereby mediate leukocyte rolling on activated endothelial cells. The major ligand of P-selectin on leukocytes is PSGL-1, which also shows some affinity for E-selectin. E-selectin recognizes ESL-1 on leukocytes. Similar to L-selectin, the extracellular portions of P- and E-selectin, sP-selectin, and sE-selectin, are present in the plasma.

Besides direct interactions with endothelial cells, leukocytes are also conducted to the endothelial monolayer by platelets, forming a bridge while binding, for example, to peripheral node addressin (PNAd) via P-selectin. Leukocytes that adhere to the vessel wall can also capture free-flowing leukocytes from the circulation. Thus a broad variety of cellular and molecular mechanisms contribute to the initial contact between leukocytes and endothelial cells.

Integrins.
Integrins mediate the firm adhesion of leukocytes by binding members of the immunoglobulin family of adhesion molecules expressed on endothelial cells. Integrins are heterodimeric molecules consisting of an {alpha}-subunit and a noncovalently-bound ß-subunit. They represent a large protein family that is classified by the ß-subunits. ß1- (CD29), ß2- (CD18), ß3- (CD61), and ß7-integrins are engaged in leukocyte recruitment, with ß2-integrins playing the key role in mediating firm adhesion of human PMN subsequent to selectin-mediated rolling. Leukocyte rolling constitutes a prerequisite for ß2-integrin-mediated firm adhesion in vivo, since ß2-integrins are not able to bind their ligands unless the velocity of passing leukocytes is slowed down to a critical value by selectin-based rolling.

There exist four different ß2-integrins (CD11/CD18) designated according to the {alpha}-subunit: lymphocyte function-associated antigen 1 or LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18), gp150/95 (CD11c/CD18), and CD11d/CD18. ß2-integrins mediate firm adhesion of leukocytes to endothelial cells by binding to intercellular adhesion molecules (ICAMs), members of the immunoglobulin superfamily that are expressed by endothelial cells. The most important ß2-integrin that mediates firm adhesion is LFA-1, which is constitutively expressed on virtually all leukocytes. LFA-1 exerts its function primarily by binding ICAM-1, which is upregulated on the inflamed endothelium. Mac-1 also has some affinity for ICAM-1, but its role in mediating adhesion is thought to be less important. LFA-1 also binds to ICAM-2, which is constitutively expressed by endothelial cells. Moreover, LFA-1 recognizes ICAM-3, which is expressed on leukocytes and mediates leukocyte-leukocyte interaction. Besides the affinity for ICAM-1, Mac-1 shows affinity for ligands such as fibrinogen, factor X, and C3bi. gp150/95 binds ICAM-1, fibrinogen, and C3bi. CD11d/CD18 is a receptor for VCAM-1 and ICAM-3. ß2-integrins as well as other integrins are physically linked to the integrin-associated protein IAP (CD47), which is thought to contribute to the regulation of integrin function.

The ß1-integrins are primarily expressed on lymphocytes and monocytes. Very late antigen 4 (VLA-4, {alpha}41, CD49d/CD29) plays a major role in mediating monocyte extravasation by binding to inducible vascular adhesion molecule 1 (VCAM-1, CD106). ß1-integrins have a subordinate function in extravasation of PMN, which show only minimal expression of this integrin. The {alpha}v3-integrin (CD51/CD61) serves as a receptor for the extracellular matrix protein vitronectin and plays a role in migration of PMN. The {alpha}47-integrin (CD49d/ß7) binds MAdCAM-1 and VCAM-1 and mediates lymphocyte homing to Peyer's patches and the lamina propria.

Immunoglobulins.
The most important adhesion molecules of the immunoglobulin superfamily that serve as ligands for the integrins during leukocyte-endothelial cell interactions are the ICAMs termed ICAM-1 (CD54), ICAM-2 (CD102), ICAM-3 (CD50), and VCAM-1 (CD106). ICAM-1 is strongly upregulated on endothelial cells upon activation by inflammatory mediators such as TNF-{alpha}. ICAM-1 binds LFA-1 with strong affinity, shows some affinity for Mac-1, and putatively binds gp150/95. As mentioned above, ICAM-1 serves as the major endothelial ligand that mediates firm adhesion of PMN to inflamed endothelial cells and therefore plays a central role in PMN recruitment to sites of inflammation. In contrast to ICAM-1, ICAM-2 is constitutively expressed on endothelial cells and its expression is virtually unaffected by inflammatory mediators. ICAM-2, which binds LFA-1 with high affinity, is also expressed on some leukocyte populations but is absent on PMN. ICAM-2 is considered to be involved primarily in lymphocyte homing. ICAM-3 (CD50) is highly expressed on leukocytes but absent on endothelial cells. ICAM-3 binds LFA-1 with high affinity and thereby mediates leukocyte-leukocyte interactions. VCAM-1 (CD106) is expressed primarily on endothelial cells and is upregulated upon stimulation by various inflammatory mediators, especially cytokines. VCAM-1 plays a role in mediating leukocyte-endothelial interactions by binding to the {alpha}41 and the {alpha}47-integrins as well as to the ß2-integrin CD11d/CD18. Platelet endothelial cell adhesion molecule (PECAM-1) (CD31), another member of the immunoglobulin family, is highly expressed on PMN and monocytes as well as on endothelial cells, exerts homotypic interactions, and binds to {alpha}v3. CD31 is considered to mediate leukocyte-endothelial cell interactions as well as transendothelial migration of leukocytes.

Other adhesion molecules.
Cadherins represent another family of adhesion molecules that is primarily characterized by exerting homotypic adhesion. E-cadherin is expressed on endothelial cells at close cellular contacts in the adherens junctions. Dissociation of the E-cadherin interactions is currently considered to occur during transendothelial migration of leukocytes. E-cadherin also binds {alpha}E/ß7 and may contribute to lymphocyte homing to intestinal epithelium. Besides this, other molecules, such as CD44 and vascular adhesion protein 1 (VAP-1), may be involved in leukocyte trafficking, but the biological significance of these are still under investigation.


    How is the inflammatory cascade initiated? Insights from the molecular mechanisms of leukocyte-endothelial cell interactions
 Top
 Introduction
 How are leukocytes made...
 How do leukocytes penetrate...
 How is the inflammatory...
 References
 
Adhesion and emigration.
The acute inflammatory response elicited upon invasion of microorganisms or upon tissue damage is associated with the release of proinflammatory mediators by tissue macrophages, mast cells, or other tissue cells such as damaged fibroblasts. Soluble mediators like histamine, interleukin 1, and TNF-{alpha} activate the endothelium lining postcapillary venules, i.e., they induce the expression of adhesion molecules and the secretion of soluble mediators, which in turn allow the leukocyte-endothelial cell interactions. The diversity and specificity of the adhesion molecules expressed constitute the molecular basis for the site-directed traveling of leukocytes during inflammation (2). The sequence of molecular mechanisms during PMN recruitment in acute inflammation is shown in Fig. 3Go. The induction of the L-selectin ligand on the microvascular endothelium by tissue-derived proinflammatory mediators allows initial capture and rolling of PMN via L-selectin. Rolling is also supported by upregulation of endothelial P- and E-selectin, which serve as receptors for PSGL-1 and ESL-1. PMN recruitment subsequent to rolling critically requires ß2-integrin-mediated firm adhesion of the PMN to the endothelial cells. Patients suffering from leukocyte adhesion deficiency type I, an inheritable defect of the CD18 gene of the ß2-integrins, show a lack of inflammatory response: PMN extravasation does not occur despite the presence of inflammatory agents (6). This is consistent with the finding that gene-targeted CD18-deficient mice show impaired PMN recruitment. In contrast, extravasation of monocytes that predominantly emigrate via ß1-integrin-dependent mechanisms is not diminished in the absence of ß2-integrins (15). The dependence of PMN emigration on ß2-integrins is thought to result from their ability to bind ICAM-1 on activated endothelial cells. Adhesive interactions of the ß2-integrins require integrin activation, i.e., functional upregulation of their ligand-binding affinity by a process termed inside-out signaling. It is elicited by soluble inflammatory mediators from activated endothelial cells to which the PMN are exposed while rolling on the inflamed vessel wall. Thus substantial PMN recruitment from the circulating blood can only occur if endothelial cells are sufficiently activated to stimulate the PMN to activate ß2-integrins and firmly adhere to the vessel wall. Besides soluble mediators, engagement of L-selectin and PSGL-1 is also considered to trigger the functional upregulation of ß2-integrins and thereby support firm adhesion. Adherent PMN spread on the endothelium transmigrate through the intercellular junctions of the endothelial cells and finally penetrate the basement membrane. Recent data suggest that adhesion preferentially occurs near the margins of the endothelial cells and thus in the vicinity of the endothelial junctions, through which the PMN eventually escape.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 3. Molecular events of PMN-endothelial cell interactions in inflammation. PSGL, P-selectin ligand; ESL, E-selectin ligand.

 
Chemotactic migration.
The finding that adhesion molecules are responsible for the targeting of leukocytes to inflamed areas led to reinvestigation of how different leukocyte populations become selectively activated to emigrate and navigate through the tissue space. Subsequent to firm adhesion and transendothelial migration, the leukocytes are recruited chemotactically to their target regions by a variety of soluble mediators (12) . Although the major principles of chemotactic migration of leukocytes are well documented, especially by in vitro experiments (5), the way chemoattractants direct their effector cells in inflammation is not entirely understood. This is due to the great complexity of this process in vivo, where many different mediators act in concert, are released by different cell types upon various stimuli, show pleiotropic functions, and act on different cell types.

Chemoattractants that guide PMN during inflammation include classical inflammatory mediators such as platelet-activating factor (PAF), leukotriene B4 (LTB4), chemoattractant cytokines such as interleukin-8 (which are also designated as chemokines), the complement factor C5a, and exogenous components like bacteria-derived peptides such as the N-formylated tripeptide Met-Leu-Phe. Chemoattractants exert their effects by binding to specific receptors on the leukocyte surface that share common features: they are heptahelical molecules with seven transmembrane domains that activate intracellular signal transduction cascades via GTP-binding proteins (G proteins). Some of these receptors, including that for interleukin 8, show promiscuous ligand binding by exerting affinity to other structurally related chemoattractants, i.e., the chemokines epithelial-derived neutrophil attractant-78 (ENA-78), neutrophil activating peptide 2 (NAP-2), and melanoma growth-stimulating activity (GRO). Moreover, some chemoattractants bind to different receptors, whereas one type of receptor is often expressed by more than one leukocyte population: bacteria-derived N-formyl-peptides, for example, are chemoattractants for both PMN and monocytes. Other mediators, like secondary lymphoid tissue chemokine (SCL), which attracts T cells, or B lymphocyte chemoattractant (BCL), which is chemotactic for B cells, act primarily on lymphocytes.

How is the activation of PMN controlled and prevented from exploding? Development of weaponry and mechanisms of containment
The pattern of adhesion molecules expressed represents the critical checkpoint for leukocyte extravasation in inflammation by determining the quantity and quality of leukocyte-endothelium interactions as well as its time course. This has unequivocally been shown by the use of monoclonal antibodies or by gene disruption in experimental animals. But adhesion molecules also play a important role subsequent to PMN emigration. Severe inflammatory responses are eventually accompanied by plasma exudation, which allows clotting in the extravascular space. This provides an appropriate matrix for ß2-integrin-mediated adhesion of emigrated PMN. By serving as receptor for C3bi-opsonized material, the ß2-integrin Mac-1 also facilitates phagocytosis and thereby promotes clearance of the tissue from foreign particles. PMN destroy ingested material by reactive oxygen metabolites, which are produced upon activation of NADPH oxidase. The destructive potential of PMN is further due to the contents of granules, i.e., enzymes such as elastase and cathepsin G, myeloperoxidase, and others, which can be released from the cells by exocytosis and contribute to tissue damage in inflammation.

But adhesion molecules not only mediate interaction of PMN with the environment: Upon ligand binding, several adhesion molecules, such as integrins, transduce signals into the cell that control adhesion-related processes, including firm attachment and spreading and, moreover, contribute to the activation of cellular functions (3). Thus integrins as well as other adhesion molecules integrate ligand-dependent, i.e., site-specific, and signaling functions at the molecular level. Early studies revealed that ß2-integrins initiate intracellular signal transduction processes and serve as costimulators, e.g., upon activation of PMN by soluble mediators such as TNF-{alpha} (9). This functional cooperation between locally released soluble mediators and integrins provides a site-specific extracellular signal pattern and may help to control PMN activation in inflammation. Tissue cells in inflamed areas are known to upregulate ICAM-1, the counterreceptor for ß2-integrins, which allows adhesive interaction between tissue cells and emigrated PMN. Since ß2-integrin engagement induces and/or promotes several biological responses of PMN, including degranulation and production of reactive oxygen metabolites, this may increase the efficiency of host defense. By precisely directing the destructive material to the target area, i.e., an injured tissue cell, this mechanism prevents the uncontrolled release of the histotoxic contents of PMN that could otherwise result in excessive tissue damage. The engagement of ß2-integrins upon costimulation by TNF-{alpha} even triggers the activation of apoptosis, the programmed cell death, of human PMN (14). Thus integrins not only contribute to the control of PMN recruitment from the circulation and to the ordered activation of their defense functions in the tissue but also mediate their final elimination. Since apoptotic PMN are specifically recognized and engulfed by macrophages and tissue cells such as fibroblasts, apoptosis of PMN is currently discussed as a key mechanism that allows the resolution of acute inflammation.

How is the process of repair and tissue remodeling initiated? Toward a new definition of inflammation
Although the mechanisms of inflammation described above are still within the framework of Metchnikoff's concept, growing evidence implies that the inflammatory response must be placed into a greater context of tissue homeostasis. Beyond its immediate physiological function, the inflammatory reaction seems to cover more than an effective host defense mechanism. Patients suffering from leukocyte adhesion deficiency type I not only show compromised leukocyte recruitment due to the absence of ß2-integrins but also show impaired wound healing. Thus inflammatory leukocyte infiltration seems to give rise to wound repair and tissue remodeling, which eventually allows restitutio ad integrum. On the molecular and cellular levels, this requires production and reconstitution of extracellular matrix, cell proliferation and differentiation, as well as more complex processes such as induction of angiogenesis and vascularization. Growing evidence suggests that these processes can be initiated or promoted by inflammatory cytokines such as interleukin-1, which induces, for example, proliferation of fibroblasts and matrix production. The present evidence that the inflammatory response does not end with the elimination of foreign particles may imply the requirement of a novel definition of inflammation. However, the biological significance of these findings remains to be proven and further investigations are required to provide the molecular basis for the understanding of the mechanisms by which inflammation may integrate host defense, wound repair, and tissue remodeling.


    References
 Top
 Introduction
 How are leukocytes made...
 How do leukocytes penetrate...
 How is the inflammatory...
 References
 

  1. Barclay, A. N., M. H. Brown, S. K. A. Law, A. J. McKnight, M. G. Tomlinson, and P. A. van der Merwe. The Leukocyte Antigen Facts Book (2nd ed.). San Diego, CA: Academic, 1997.
  2. Butcher, E. C. Leukocyte-endothelial cell recognition—three (or more) steps to specificity and diversity. Cell 67: 1033–1036, 1991.[Web of Science][Medline]
  3. Clark, E. A., and J. S. Brugge. Integrins and signal transduction pathways: the road taken. Science 268: 233–239, 1995.[Abstract/Free Full Text]
  4. Cohnheim, J. Vorlesungen über allgemeine Pathologie. Berlin: August Hirschwald Verlag, 1877.
  5. Foxman, E. F., J. J. Campbell, and E. C. Butcher. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell. Biol. 139: 1349–1360, 1997.[Abstract/Free Full Text]
  6. Hawkins, E. P., S. C. Heffelfinger, and D. C. Anderson. Leukocyte adhesion deficiency: clinical and postmortem observations. Pediatr. Pathol. 12: 119–130, 1992.[Web of Science][Medline]
  7. Ley, K., P. Gaehtgens, F. Cristopher, M. S. Singer, L. A. Lasky, and S. D. Rosen. Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 12: 2553–2555, 1991.
  8. Metchnikoff, M. E. Lectures on the Comparative Pathology of Inflammation. London: Kegan, Paul, Trench ( Truebner, 1893.
  9. Nathan, C., S. Srimal, C. Farber, E. Sanchez, L. Kabbash, A. Asch, J. Gailit, and S. D. Wright. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J. Cell. Biol. 109: 1341–1349, 1989.[Abstract/Free Full Text]
  10. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301–314, 1994.[Web of Science][Medline]
  11. Virchow, R. Die Cellularpathologie in ihrer Begründung auf die physiologische und pathologische Gewebelehre. Berlin: August Hirschwald Verlag; 1871.
  12. Vaddi, K., M. Keller, and R. Newton. The Chemokine Facts Book. San Diego, CA: Academic, 1997.
  13. Von Andrian, U. H., S. R. Hasslen, R. D. Nelson, S. L. Erlandsen, and E. C. Butcher. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell 82: 989–999, 1995.[Web of Science][Medline]
  14. Walzog, B., F. Jeblonski, A. Zakrzewicz, and P. Gaehtgens. ß2 integrins (CD11/ CD18) promote apoptosis of human neutrophils. FASEB J. 11: 1177–1186, 1998.[Abstract]
  15. Walzog, B., K. Scharffetter-Kochanek, and P. Gaehtgens. Impairment of neutrophil emigration in CD18 null mice. Am. J. Physiol. Gastrointest. Liver Physiol. 276: G1125–G1130, 1999.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
L. Ramudo, I. De Dios, S. Yubero, S. Vicente, and M. A. Manso
ICAM-1 and CD11b/CD18 Expression During Acute Pancreatitis Induced by Bile-Pancreatic Duct Obstruction: Effect of N-Acetylcysteine
Experimental Biology and Medicine, June 1, 2007; 232(6): 737 - 743.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. X Pizza, J. M Peterson, J. H Baas, and T. J Koh
Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice
J. Physiol., February 1, 2005; 562(3): 899 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Cettour-Rose, T. X. K. Nguyen, L. Serrander, M.-T. Kaufmann, J.-M. Dayer, D. Burger, and P. Roux-Lombard
T cell contact-mediated activation of respiratory burst in human polymorphonuclear leukocytes is inhibited by high-density lipoproteins and involves CD18
J. Leukoc. Biol., January 1, 2005; 77(1): 52 - 58.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. A. Aller, J. L. Arias, M. P. Nava, and J. Arias
Posttraumatic Inflammation Is a Complex Response Based on the Pathological Expression of the Nervous, Immune, and Endocrine Functional Systems
Experimental Biology and Medicine, February 1, 2004; 229(2): 170 - 181.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Dyugovskaya, P. Lavie, and L. Lavie
Phenotypic and Functional Characterization of Blood {gamma}{delta} T Cells in Sleep Apnea
Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J.-G. Castaigne, W. Guo, C. Leveille, D. Charron, and R. Al-Daccak
A CD18-dependent protein kinase C {beta}-mediated alternative cell death pathway of activated monocytes
Int. Immunol., September 1, 2002; 14(9): 1003 - 1014.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walzog, B.
Right arrow Articles by Gaehtgens, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walzog, B.
Right arrow Articles by Gaehtgens, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online